Alessandro Maria Vannucchi

机构：Azienda Ospedaliero-Universitaria Careggi, University of Florence · ORCID：0000-0001-5755-0730

发表论文 1242 篇 · 总被引 56010 次 · h-index 111

代表论文

• Genomic profiling for decision-making in post–polycythemia vera and post–essential thrombocythemia myelofibrosis (2026 · Blood · 被引 10)
• JAK inhibitor selection in challenging scenarios of myelofibrosis: a review (2025 · Haematologica · 被引 8)
• Phase 2 study of the lysine-specific demethylase 1 inhibitor bomedemstat for essential thrombocythemia (2026 · Blood Advances · 被引 4)
• Rusfertide or placebo plus current standard-of-care therapy for polycythemia vera: Durability of response and safety results through week 52 from the randomized controlled phase 3 VERIFY study (2025 · Blood · 被引 3)
• Autoimmune and Inflammatory Diseases in Polycythemia Vera and Essential Thrombocythemia: Impact on Disease Outcomes and Comorbidities (2026 · American Journal of Hematology · 被引 2)
• Changes in neutrophil-to-lymphocyte ratio in patients with polycythemia vera treated with ruxolitinib reflect JAK2 variant allele frequency (2026 · Haematologica · 被引 2)